Home AnTolRx

AnTolRx

In operation
Series A
Targeted Therapy Developer
Basic
Enterprise Profile

Basic Information

AnTolRx Addresses Significant Unmet Needs in Autoimmunity by Developing Novel Proprietary Therapies for Disease Treatment. Our Platform Approach Involves Creating New Targeted Therapies That Leverage Specific Autoantigens and Unique Tolerogenic Molecules to Actively Promote Immune Tolerance. Our Patented Nanotechnology is Designed to Induce Antigen-Specific Immune Tolerance.
AnTolRx, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2015
info@antolrx.com

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Targeted Technology Immunological Techniques
Concept
Immune System Diseases # Diabetes Mellitus
Application Scenarios
Innovative Drugs Nanotechnology